81 results
8-K
BTAX
Biostax Corp.
14 Sep 23
Biostax Corp Announces the Passing of Esteemed Director, Henry Louis Salomonsky
9:00am
terminology that concern the Company’s expectations, strategy, plans, or intentions. Forward-looking statements relating to expectations about future results … , the effectiveness of its growth strategy, its market opportunity, and demand for its products and services in general. The Company’s expectations
8-K
899r gbn9
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
PRE 14C
ywjlfzqw0p pc
16 Dec 22
Preliminary information
4:31pm
8-K
EX-99.1
2q9 u73jcc
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
jtv424c2mv97ybpe4
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
EX-99.1
z94qgq96
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
EX-99.1
kwknfv6zz42t9udmz
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-99.1
a3ushtepvocth5
3 Jun 22
Departure of Directors or Certain Officers
4:57pm